0 01/03/2026 15/03/2026 2026-03-15 false false false false false false false true false false true false false false false false true false No description of principal activities is disclosed 2026-03-01 Sage Accounts Production 25.0 - FRS102_2024 xbrli:pure xbrli:shares iso4217:GBP 4115929 2026-03-01 2026-03-15 4115929 2026-03-15 4115929 2026-02-28 4115929 2025-03-01 2026-02-28 4115929 2026-02-28 4115929 2025-02-28 4115929 bus:RegisteredOffice 2026-03-01 2026-03-15 4115929 bus:LeadAgentIfApplicable 2026-03-01 2026-03-15 4115929 bus:Director1 2026-03-01 2026-03-15 4115929 bus:Director2 2026-03-01 2026-03-15 4115929 bus:Director3 2026-03-01 2026-03-15 4115929 bus:Micro-entities 2026-03-01 2026-03-15 4115929 bus:AuditExemptWithAccountantsReport 2026-03-01 2026-03-15 4115929 bus:SmallCompaniesRegimeForAccounts 2026-03-01 2026-03-15 4115929 bus:PrivateLimitedCompanyLtd 2026-03-01 2026-03-15 4115929 bus:FullAccounts 2026-03-01 2026-03-15
Company registration number: 4115929
KAAM PHARMA LIMITED
Unaudited filleted financial statements
15 March 2026
KAAM PHARMA LIMITED
Contents
Directors and other information
Accountant's report
Statement of financial position and notes to the financial statements
KAAM PHARMA LIMITED
Directors and other information
Directors Mr M K Patel
Mr A Makadia
Mrs Hital Patel
Company number 4115929
Registered office 1st Floor, Fairclough House
Church Street
Chorley
Lancashire
PR7 4EX
Accountant Mak Plus Limited
9 Westfield Drive
Harrow
Middlesex
HA3 9EG
KAAM PHARMA LIMITED
Accountant's report to the board of directors on the preparation of the
unaudited statutory financial statements of Kaam Pharma Limited
Period ended 15 March 2026
As described on the Statement of financial position, the directors of the company are responsible for the preparation of the financial statements for the period ended 15 March 2026, as set out on pages 3 to 3.
You consider that the company is exempt from an audit under the Companies Act 2006. In accordance with your instructions I have compiled these unaudited financial statements in order to assist you to fulfil your statutory responsibilities, from the accounting records and from information and explanations supplied to me.
Mak Plus Limited
Accountants and Tax Consultants
9 Westfield Drive
Harrow
Middlesex
HA3 9EG
31 March 2026
KAAM PHARMA LIMITED
Statement of financial position
15 March 2026
15/03/26 28/02/26
£ £
Current assets 2,261,214 2,261,214
Net current assets 2,261,214 2,261,214
_________ _________
Total assets less current liabilities 2,261,214 2,261,214
_________ _________
Net assets 2,261,214 2,261,214
_________ _________
Capital and reserves 2,261,214 2,261,214
_________ _________
Notes to the financial statements
KAAM PHARMA LIMITED
Period ended 15 March 2026
1. Employee numbers
The average number of persons employed by the company during the period amounted to Nil (2026: 8 ).
For the period ending 15 March 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors responsiblities:
- The members have not required the company to obtain an audit of its accounts for the period in question in accordance with section 476.
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
The financial statements have been prepared in accordance with the micro-entity provisions and have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.
These financial statements were approved by the board of directors and authorised for issue on 31 March 2026 , and are signed on behalf of the board by:
Mr M K Patel
Director
Company registration number: 4115929
The company is a private company limited by shares, registered in England & Wales.